187 related articles for article (PubMed ID: 20074543)
1. Enrichment of cysteinyl adducts of human serum albumin.
Funk WE; Li H; Iavarone AT; Williams ER; Riby J; Rappaport SM
Anal Biochem; 2010 May; 400(1):61-8. PubMed ID: 20074543
[TBL] [Abstract][Full Text] [Related]
2. Direct observation of covalent adducts with Cys34 of human serum albumin using mass spectrometry.
Beck JL; Ambahera S; Yong SR; Sheil MM; de Jersey J; Ralph SF
Anal Biochem; 2004 Feb; 325(2):326-36. PubMed ID: 14751268
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Posttranslational Modification and the Functional Impairment of Human Serum Albumin in Commercial Preparations.
Miyamura S; Imafuku T; Anraku M; Taguchi K; Yamasaki K; Tominaga Y; Maeda H; Ishima Y; Watanabe H; Otagiri M; Maruyama T
J Pharm Sci; 2016 Mar; 105(3):1043-9. PubMed ID: 26928399
[TBL] [Abstract][Full Text] [Related]
4. Profiling Cys34 adducts of human serum albumin by fixed-step selected reaction monitoring.
Li H; Grigoryan H; Funk WE; Lu SS; Rose S; Williams ER; Rappaport SM
Mol Cell Proteomics; 2011 Mar; 10(3):M110.004606. PubMed ID: 21193536
[TBL] [Abstract][Full Text] [Related]
5. Bioanalytical verification of V-type nerve agent exposure: simultaneous detection of phosphonylated tyrosines and cysteine-containing disulfide-adducts derived from human albumin.
Kranawetvogl A; Küppers J; Siegert M; Gütschow M; Worek F; Thiermann H; Elsinghorst PW; John H
Anal Bioanal Chem; 2018 Feb; 410(5):1463-1474. PubMed ID: 29322229
[TBL] [Abstract][Full Text] [Related]
6. Cys34 adducts of reactive oxygen species in human serum albumin.
Grigoryan H; Li H; Iavarone AT; Williams ER; Rappaport SM
Chem Res Toxicol; 2012 Aug; 25(8):1633-42. PubMed ID: 22591159
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry.
Kleinova M; Belgacem O; Pock K; Rizzi A; Buchacher A; Allmaier G
Rapid Commun Mass Spectrom; 2005; 19(20):2965-73. PubMed ID: 16178042
[TBL] [Abstract][Full Text] [Related]
8. Untargeted adductomics of Cys34 modifications to human serum albumin in newborn dried blood spots.
Yano Y; Grigoryan H; Schiffman C; Edmands W; Petrick L; Hall K; Whitehead T; Metayer C; Dudoit S; Rappaport S
Anal Bioanal Chem; 2019 Apr; 411(11):2351-2362. PubMed ID: 30783713
[TBL] [Abstract][Full Text] [Related]
9. A tandem MS precursor-ion scan approach to identify variable covalent modification of albumin Cys34: a new tool for studying vascular carbonylation.
Aldini G; Regazzoni L; Orioli M; Rimoldi I; Facino RM; Carini M
J Mass Spectrom; 2008 Nov; 43(11):1470-81. PubMed ID: 18457351
[TBL] [Abstract][Full Text] [Related]
10. Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases.
Nagumo K; Tanaka M; Chuang VT; Setoyama H; Watanabe H; Yamada N; Kubota K; Tanaka M; Matsushita K; Yoshida A; Jinnouchi H; Anraku M; Kadowaki D; Ishima Y; Sasaki Y; Otagiri M; Maruyama T
PLoS One; 2014; 9(1):e85216. PubMed ID: 24416365
[TBL] [Abstract][Full Text] [Related]
11. Antibody enrichment and mass spectrometry of albumin-Cys34 adducts.
Chung MK; Grigoryan H; Iavarone AT; Rappaport SM
Chem Res Toxicol; 2014 Mar; 27(3):400-7. PubMed ID: 24328277
[TBL] [Abstract][Full Text] [Related]
12. Survey of albumin purification methods for the analysis of albumin-organic toxicant adducts by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Young CL; Woolfitt AR; McWilliams LG; Moura H; Boyer AE; Barr JR
Proteomics; 2005 Dec; 5(18):4973-9. PubMed ID: 16267814
[TBL] [Abstract][Full Text] [Related]
13. Immunodetection of serum albumin adducts as biomarkers for organophosphorus exposure.
Chen S; Zhang J; Lumley L; Cashman JR
J Pharmacol Exp Ther; 2013 Feb; 344(2):531-41. PubMed ID: 23192655
[TBL] [Abstract][Full Text] [Related]
14. HPLC separation of human serum albumin isoforms based on their isoelectric points.
Turell L; Botti H; Bonilla L; Torres MJ; Schopfer F; Freeman BA; Armas L; Ricciardi A; Alvarez B; Radi R
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 944():144-151. PubMed ID: 24316526
[TBL] [Abstract][Full Text] [Related]
15. Automated detection of covalent adducts to human serum albumin by immunoaffinity chromatography, on-line solution phase digestion and liquid chromatography-mass spectrometry.
Hoos JS; Damsten MC; de Vlieger JS; Commandeur JN; Vermeulen NP; Niessen WM; Lingeman H; Irth H
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(2):147-56. PubMed ID: 17913598
[TBL] [Abstract][Full Text] [Related]
16. Human serum albumin cysteinylation is increased in end stage renal disease patients and reduced by hemodialysis: mass spectrometry studies.
Regazzoni L; Del Vecchio L; Altomare A; Yeum KJ; Cusi D; Locatelli F; Carini M; Aldini G
Free Radic Res; 2013 Mar; 47(3):172-80. PubMed ID: 23215783
[TBL] [Abstract][Full Text] [Related]
17. Identification and quantification of drug-albumin adducts in serum samples from a drug exposure study in mice.
Switzar L; Kwast LM; Lingeman H; Giera M; Pieters RH; Niessen WM
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Feb; 917-918():53-61. PubMed ID: 23353939
[TBL] [Abstract][Full Text] [Related]
18. A mass spectrometric investigation of the binding of gold antiarthritic agents and the metabolite [Au(CN)2]- to human serum albumin.
Talib J; Beck JL; Ralph SF
J Biol Inorg Chem; 2006 Jul; 11(5):559-70. PubMed ID: 16791640
[TBL] [Abstract][Full Text] [Related]
19. Dual labeling of biomolecules using MeCAT and DOTA derivatives: application to quantitative proteomics.
El-Khatib AH; Esteban-Fernández D; Linscheid MW
Anal Bioanal Chem; 2012 Jun; 403(8):2255-67. PubMed ID: 22411540
[TBL] [Abstract][Full Text] [Related]
20. Extending the HSA-Cys34-Adductomics Pipeline to Modifications at Lys525.
Grigoryan H; Imani P; Dudoit S; Rappaport SM
Chem Res Toxicol; 2021 Dec; 34(12):2549-2557. PubMed ID: 34788011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
